Archive for June 29th, 2011

Clinical updates for ZCLS THLD. APPA raising cash. BCRX mixed shelf

Jun 29, 2011 No Comments by

BioCryst Pharmaceuticals, Inc (Nasdaq: BCRX) filed a mixed shelf to the value of $70m after hours yesterday. Zalicus Inc. (NASDAQ:ZLCS) today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA). Top-line results of the […]

Daily News Read more